Clinical and theoretical context
Chronic insomnia is the focus of this evidence, rather than every difficult night or all causes of daytime tiredness. CBT-I combines cognitive and behavioural work tailored to sleep difficulties. The American Academy of Sleep Medicine (AASM) strongly recommends multicomponent CBT-I, drawing mainly on trials involving trained treatment providers. It conditionally recommends against sleep hygiene as the sole treatment (Edinger et al., 2021). This distinction matters for public education: regularity and a comfortable sleep environment may be sensible topics, but a checklist is not an evidence-equivalent substitute for the clinical programme.
Sources: Edinger et al., 2021
What component studies can and cannot establish
Two 2024 network meta-analyses examined which CBT-I components were associated with benefit. Furukawa et al. emphasized remission and found associations for cognitive restructuring, third-wave elements, sleep restriction and stimulus control. Steinmetz et al. emphasized insomnia severity. Its original abstract incorrectly omitted a small significant cognitive-therapy effect; a published corrigendum restores that finding and corrects the sleep-restriction confidence interval (Furukawa et al., 2024; Steinmetz et al., 2024a, 2024b). Reading only the original abstract would create a misleading disagreement. Even corrected component networks infer contributions from packages in which elements co-occur. Outcomes, coding and additivity assumptions affect estimates. These results should guide hypotheses for dismantling trials, not instructions to remove a component from an individual’s care.
Sources: Furukawa et al., 2024; Steinmetz et al., 2024b; Steinmetz et al., 2024a
A 2026 update on combination treatment
A new AASM guideline distinguishes two comparisons: CBT-I plus medication versus medication alone, and that combination versus CBT-I alone. Its conditional recommendations favour the combination over medication alone but do not favour routine combination over CBT-I alone. Both recommendations rely on low-certainty evidence (Buysse et al., 2026). The direction depends on the comparator and does not justify telling readers to start or discontinue medicine. Preference-sensitive decisions and treatment burden remain part of clinical care. The update also illustrates why a recent publication date should be separated from its evidence-search date.
Sources: Buysse et al., 2026
Durability, adverse effects and applicability
The evidence should distinguish symptom remission from changes in sleep timing, daytime function and quality of life. Component studies concentrating on post-treatment outcomes cannot independently establish lasting remission. Early sleepiness and fatigue can occur during CBT-I; particular behavioural components may require adaptation for driving-related work, mania vulnerability, seizure disorders or mobility limitations (Edinger et al., 2021). A reassuring label such as “natural” is therefore not an adequate safety description. The clinical implication is assessment and appropriate support, rather than a self-directed sleep-restriction schedule on a general research page.
Sources: Edinger et al., 2021; Furukawa et al., 2024; Steinmetz et al., 2024b
Implications for digital self-help
These findings can inform accurate education about sleep, but a generic app should not claim CBT-I efficacy merely because it discusses sleep-related thoughts. A digital intervention needs its own specified protocol, suitable population and evidence for the level of human support actually provided. This is a research requirement inferred from the mismatch between clinical programmes and broad reflection tools. Useful studies would examine engagement, daytime impairment, sustained benefit, treatment-related sleepiness and access for people with comorbid conditions. Comparing the delivered programme with credible sleep education or another active option would clarify what it adds. Company-specific effectiveness remains unestablished by these sources.
Sources: Edinger et al., 2021; Furukawa et al., 2024; Buysse et al., 2026
References
Links open the original papers or official sources. Access labels describe the material assessed for this review.
Edinger, J. D., Arnedt, J. T., Bertisch, S. M., Carney, C. E., Harrington, J. J., Lichstein, K. L., Sateia, M. J., Troxel, W. M., Zhou, E. S., Kazmi, U., Heald, J. L., & Martin, J. L. (2021). Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 17(2), 255–262. 10.5664/jcsm.8986
Access assessed: Full PMC text.
Furukawa, Y., Sakata, M., Yamamoto, R., Nakajima, S., Kikuchi, S., Inoue, M., Ito, M., Noma, H., Takashina, H. N., Funada, S., Ostinelli, E. G., Furukawa, T. A., Efthimiou, O., & Perlis, M. (2024). Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Insomnia in Adults: A Systematic Review and Component Network Meta-Analysis. JAMA Psychiatry, 81(4), 357–365. 10.1001/jamapsychiatry.2023.5060
Access assessed: Full PMC text.
Steinmetz, L., Simon, L., Feige, B., Riemann, D., Johann, A. F., Ell, J., Ebert, D. D., Baumeister, H., Benz, F., & Spiegelhalder, K. (2024b). Network meta-analysis examining efficacy of components of cognitive behavioural therapy for insomnia. Clinical Psychology Review, 114, 102507. 10.1016/j.cpr.2024.102507
Access assessed: Indexed PubMed abstract plus indexed publisher methods/limitations; original full article not appraised. Full published correction assessed separately (B27).
Steinmetz, L., Simon, L., Feige, B., Riemann, D., Johann, A. F., Ell, J., Ebert, D. D., Baumeister, H., Benz, F., & Spiegelhalder, K. (2024a). Corrigendum to “Network meta-analysis examining efficacy of components of cognitive behavioural therapy for insomnia” [Clinical Psychology Review 114 (2024) 102507]. Clinical Psychology Review, 114, 102519. 10.1016/j.cpr.2024.102519
Access assessed: Full published correction PDF hosted by German National Library (https://d-nb.info/1351210343/34); PubMed metadata verified.
Buysse, D. J., Arnedt, J. T., Buenaver, L., Chang, J. L., Fernandez-Mendoza, J., Patel, S. I., Zhou, E. S., Falck-Ytter, Y., Hyer, S., Kazmi, U., Singh, M., & Wickwire, E. M. (2026). Combination treatment for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 22(1), Article 56. 10.1007/s44470-025-00038-8
Access assessed: Full PMC text and PubMed metadata.
This evidence review is educational. It does not provide an individual diagnosis or treatment plan. Read the review methods, access limits, and clinical-review status.